Literature DB >> 7458724

Adrenoleukodystrophy. Failure of immunosuppression to prevent neurological progression.

D A Stumpf, A Hayward, R Haas, M Frost, H H Schaumburg.   

Abstract

Severe immunosuppression with prednisone and cyclophosphamide failed to prevent neurological progression in a patient with adrenoleukodystrophy.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7458724     DOI： 10.1001/archneur.1981.00510010074014

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


  6 in total

1.  Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil".

Authors:  B M van Geel; J Assies; E B Haverkort; J H Koelman; B Verbeeten; R J Wanders; P G Barth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

Review 2.  X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy.

Authors:  B M van Geel; J Assies; R J Wanders; P G Barth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

Review 3.  Current and future pharmacological treatment strategies in X-linked adrenoleukodystrophy.

Authors:  Johannes Berger; Aurora Pujol; Patrick Aubourg; Sonja Forss-Petter
Journal:  Brain Pathol       Date:  2010-07       Impact factor: 6.508

4.  Progression of X-linked adrenoleukodystrophy under interferon-beta therapy.

Authors:  G C Korenke; H J Christen; B Kruse; D H Hunneman; F Hanefeld
Journal:  J Inherit Metab Dis       Date:  1997-03       Impact factor: 4.982

Review 5.  Adrenomyeloneuropathy as a cause of primary adrenal insufficiency and spastic paraparesis.

Authors:  Monika Spurek; Regina Taylor-Gjevre; Stan Van Uum; Hasnain M Khandwala
Journal:  CMAJ       Date:  2004-10-26       Impact factor: 8.262

Review 6.  Adrenoleukodystrophy: phenotypic variability and implications for therapy.

Authors:  H W Moser; A B Moser; K D Smith; A Bergin; J Borel; J Shankroff; O C Stine; C Merette; J Ott; W Krivit
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.